Gut microbiota-derived short-chain fatty acids regulate group 3 innate lymphoid cells in HCC.

Chupeng Hu,Bingqing Xu,Xiaodong Wang,Wen-Hua Wan,Jinying Lu,Deyuan Kong,Yu Jin,Wenhua You,Hua Sun,Xiaoxin Mu,Dongju Feng,Yun Chen

Hepatology (Baltimore, Md.)（2023）

引用 32|浏览17

暂无评分

摘要

These findings suggested that modifying bacteria, changing SCFAs, reducing IL-17A-producing ILC3 infiltration, and combining with immune checkpoint inhibitors will contribute to the clinical treatment of HCC.

查看译文

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要